home / stock / tcon / tcon news

TCON News and Press, TRACON Pharmaceuticals Inc. From 05/30/19

Stock Information
Company Name: TRACON Pharmaceuticals Inc.
Stock Symbol: TCON
Market: OTC
Website: traconpharma.com
Menu
TCON TCON Quote TCON Short TCON News TCON Articles TCON Message Board
Get TCON Alerts

News, Short Squeeze, Breakout and More Instantly...
TCON - TRACON Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference

SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, and through our license to Santen Pharmaceutical Co. Ltd., wet age‐...
TCON - TRACON Pharmaceuticals Inc. (TCON) CEO Charles Theuer on Q1 2019 Results - Earnings Call Transcript

TRACON Pharmaceuticals Inc. (TCON) Q1 2019 Earnings Conference Call May 14, 2019 16:30 ET Company Participants Charles Theuer - President & CEO Scott Brown - Director, Controller Conference Call Participants Maury Raycroft - Jefferies Jake Colby - BTIG Presentation ...

TCON - Tracon beats by $0.02

Tracon (NASDAQ: TCON ): Q1 GAAP EPS of -$0.24 beats by $0.02 . More news on: TRACON Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

TCON - TRACON Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update

SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, and through our license to Santen Pharmaceutical Co. Ltd., wet age‐...
TCON - TRACON to Report First Quarter 2019 Company Highlights and Financial Results on May 14, 2019

SAN DIEGO, May 07, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and, through our license to Santen Pharmaceutical Co. Ltd., wet age-related...

TCON - APC, PE, IMRN and MDXG among notable midday movers

Gainers:  Reebonz Holding (NASDAQ: RBZ ) +111% . Castor Maritime (NASDAQ: CTRM ) +43% . Anadarko Petroleum (NYSE: APC ) +33% . Immuron (NASDAQ: IMRN ) +27% . Enlivex Therapeutics (NASDAQ: ENLV ) +17% . Kitov Pharma (NASDAQ: KTOV ) +17% . Renren (NYSE: RENN ) +15% . Summit Wirel...

TCON - TCON and AMRS among premarket losers

Reebonz Holding (NASDAQ: RBZ ) -52% . More news on: Reebonz Holding Limited, TRACON Pharmaceuticals, Inc., X4 Pharmaceuticals, Inc., Stocks on the move, Read more ...

TCON - TRACON Pharma down 47% after termination of late-stage TAPPAS trial

TRACON Pharmaceuticals' (NASDAQ: TCON ) Phase 3 TAPPAS trial evaluating TRC105 in combination with Votrient (pazopanib) in patients with advanced or metastatic angiosarcoma was terminated for futility. More news on: TRACON Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the...

TCON - TRACON Pharmaceuticals Announces Termination of Phase 3 TAPPAS Trial Based on the Recommendation of the Independent Data Monitoring Committee

SAN DIEGO, April 12, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and, through our license to Santen Pharmaceutical Co. Ltd., wet age-relat...

TCON - GME and ADXS among premarket losers

Fusion Connect (NASDAQ: FSNN ) -82%  as audit problems prompt Chapter 11 analyst warning. More news on: Fusion Connect, Inc., Advaxis, Inc., AVEO Pharmaceuticals, Inc., Stocks on the move, Read more ...

Previous 10 Next 10